Caution on Tandem, Bullish on Vicor & Cardinal
Update: 2025-11-21
Description
Today, were examining stocks that have surged recently, like Tandem Diabetes Care and Vicor. However, were cautious about Tandem due to shipping issues and declining returns. Vicor, on the other hand, is a solid choice with consistent revenue growth and improving profitability. Cardinal Health, another winner, benefits from a dominant market position and projected revenue growth.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
